Susan Hasty, Publisher
Table of Contents . . . March 16th, 1998Non-Subscriber - Summaries Only
Conference Coverage (Blood Safety) - GAT Reduces Window Period for HIV and HCV; not HBV
Conference Coverage (Blood Safety) - No Reported Toxicity Problems with Solvent/Detergent Plasma
Conference Coverage (Blood Safety) - Simple Iodine Treatment Applicable to Plasma Products
Conference Coverage (Blood Safety) - UVC Is Suitable As Supplemental Viral Kill Treatment
Disease Associations - United Kingdom To Import Blood Plasma as "Mad Cow" Move
Drug Development - U.S. FDA Approves Hydroxyurea To Treat Sickle-Cell Anemia
Outbreak (HBV) - Hepatitis B Cases Associated With UK Alternative Therapies Clinic
Risk Factors - Patients Taking Coumadin Warned About Tylenol
Transplantation - Women, Ethnic Groups Wait Longer For Liver Transplantation
Prophylaxis (Cytomegalovirus) - Better Dosing is Required for Valaciclovir
Herpes Simples Virus Type 1 - Inhibition of Protein Synthesis Stimulates Early Gene Expression
Drug-Resistant Malaria - Isotopic In Vitro Assays Are Useful, But Require Standardization
Pathogenesis (GBV) - "Tissue Tropism of GBV-C and HCV."
Borna Disease Virus - "Mechanism of Borna Disease Virus Entry into Cells."
Cancer Vaccines - "Gene Immunotherapy in Murine Acute Myeloid Leukemia: Granulocyte-Macrophage Colony-Stimulating Factor Tumor Cell Vaccines Elicit More Potent Antitumor Immunity Compared with B7 Family and Other Cytokine Vaccines.
Education and Prevention - "HIV/AIDS-Related Social Anxieties in Adolescents in Three African Countries."
Thrombotic Thrombocytopenic Purpura - "Chronic Relapsing Thrombotic Thrombocytopenic Purpura: Role of Therapy with Cyclosporine."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.